35
Session · 35 of 35
Global Cardiovascular Health
Global cardiovascular health addresses the largest gaps in cardiovascular medicine — the inequities between regions, races and resources. Sessions cover the polypill for primary and secondary prevention in low-resource settings, rheumatic heart disease eradication programmes, tobacco-control and salt-reduction policy, hypertension control campaigns, structural and workforce capacity building, and the WHO 2030 NCD targets. Discussion includes climate change as a CV risk factor and the implementation science needed to close the gap.
Topics covered in this session
- Polypill for prevention at scale
- RHD eradication programmes
- Tobacco and salt policy
- Hypertension control campaigns
- Workforce capacity building
- Climate change and CVD
- WHO 2030 NCD targets
- Implementation science in LMICs
Other Sessions
Explore the full GCCM 2027 program
- 01Interventional Cardiology
- 02Heart Failure & Transplant
- 03Electrophysiology
- 04Preventive Cardiology
- 05Cardio-Oncology
- 06Cardiac Imaging
- 07Digital Cardiology & AI
- 08Cardiometabolic Medicine
- 09Critical Care Cardiology
- 10Structural Heart Disease
- 11Pulmonary Hypertension
- 12Cardiovascular Genomics
- 13Cardiomyopathies
- 14Hypertension
- 15Lipidology
- 16Valvular Heart Disease
- 17Heart Rhythm Disorders
- 18Coronary Artery Disease
- 19Sports Cardiology
- 20Pediatric Cardiology
- 21Geriatric Cardiology
- 22Cardiac Rehabilitation
- 23Congenital Heart Disease
- 24Pericardial Diseases
- 25Cardiovascular Surgery
- 26Vascular & Aortic Diseases
- 27Sudden Cardiac Arrest
- 28Echocardiography
- 29Nuclear Cardiology
- 30Cardiovascular Pharmacology
- 31Women's Cardiovascular Health
- 32Inflammatory Heart Disease
- 33Rheumatic Heart Disease
- 34Cardiac Nursing